Apheresis Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025
Published on : Nov-2019
|
List of Tables : 42
|
List of Figures : 106
|
No. of Pages : 170
|
Report Code : FACT4352MR
|
Format : 
Favourable Reimbursement Scenario in Developed Regions Supporting Steady Growth of Apheresis Market
The introduction of new therapy lines such as stem cell therapy, immunoglobulin therapy, and radiotherapy for control and prevention of chronic diseases is inadvertently bolstering the adoption of apheresis procedures, in turn boosting the growth of the global apheresis market. Governments of North America and Europe are diverting investments towards encouraging the adoption of quality healthcare through various programs such as Medicare, Medicaid, employee insurance programs, and Veterans Health Administration, which alleviates high-cost concerns regarding apheresis procedures.
Lack of regular blood donors is being countered by private blood collection centres that attract donors through paid plans. In recent times, hospitals are increasing the adoption of apheresis equipment to collect and store required blood components, so as to reduce dependency on private suppliers and blood collection centres. Given the influence of these dynamics, research by Fact.MR projects the apheresis market to grow 2X during the forecast period (2020 - 2025).
For detailed insights on market taxonomy, request a sample copy of the report here.
Shift from Single Dose to Double Dose Apheresis to Create Opportunities for Disposable Products
The healthcare sector is constantly plagued by a disproportionately high unmet need for blood components. As a result, a shift away from single dose towards double dose apheresis is observed to increase the yield of blood components. The shift is also creating an indispensable need to separate multiple components at once, which is driving the development of advanced products such as plasma separators and immunoadsorbent. The trend of adopting double dose apheresis procedures is specifically dominant in Japan, Germany, and the U.S. markets.
Disposables will remain preferred products in the apheresis market over devices, as advancements in apheresis equipment differentiate the types of columns, blood lines, and tubing. In addition, the frequency of use of these products is comparatively higher than the adoption of devices, which is projected to retain lucrative prospects from the sales of disposable products.
New Revenue Streams for Apheresis Procedures from Expansion of Application Scope
According to guidelines for apheresis procedures as provided by the American Society for Apheresis (ASFA), there are over 87 diseases that can be treated using the apheresis procedure as the sole line or as supportive treatment. Manufacturers of apheresis equipment are capitalizing on this opportunity to foster innovation in these products, and validate them based on evidence to target novel applications.
Among other applications, evidence-based use of apheresis procedures for neurological applications is projected to create a significant revenue stream for the apheresis market. Moreover, increasing use of radiotherapy or chemotherapy and incidence of damaged bone marrow are likely to unlock profitable avenues from apheresis procedures used for the treatment of cancer.
Understanding Impact of Underlying Challenges Present in Apheresis Market
Despite the emergence of new revenue channels for the apheresis market, there are numerous challenges present in the landscape, which could inadvertently narrow growth prospects. A key barrier to growth is the lack of skilled professionals. Recent times have witnessed an epochal scale of technological changes, which has revolutionized the healthcare industry, and, in turn, its operations. However, scarcity of expert operators leads to an increase in acquisition cost of well-informed resources, which adds up to the already high cost of apheresis procedures.
Healthcare expenses in developed regions such as North America and Europe are offset through government initiatives and reimbursement programs. However, cost concerns in developing and underdeveloped regions could shrink opportunities for players in the apheresis market, though these present highly lucrative, yet largely untapped markets.
For detailed regional analysis, request a sample copy of the report here.
Cost-competitiveness - A Key Strategy to Grow in Developing Regions
High technological prowess coupled with government aid supporting research & development activities is increasing the concentration of manufacturers in North America. Advancements in the healthcare sector and progressive improvements in the quality of services have been increasing patients’ reliance on hospitals and clinics. Besides this, easy access to advanced apheresis products, on the backdrop of ongoing development initiatives undertaken by market players, further expands the patient pool in the region. Considering these drivers, North America is expected to lead the growth of the apheresis market, with the regional market registering a CAGR of ~10% during the forecast period.
Among other regions, manufacturers in the apheresis market in Japan are taking the technological approach to foster innovation in the development of apheresis products, which is anticipated to strengthen the Asia Pacific apheresis market. Though reimbursement scenarios are likely to offer coverage in developing countries in future, it is imperative that market players adopt a cost-competitive strategy to achieve better penetration rate of products in these regions.
Request research methodology of this report.
Apheresis Market - Scope of the Study
Fact.MR, in its recently published research report on the apheresis market, offers actionable intelligence and key winning strategies for stakeholders in the global apheresis market. This exclusive study provides rare and relevant insights into weighted dynamics, which directly or indirectly influence the growth of the apheresis market during the forecast period (2020 - 2025).
With the help of key insights offered by this exclusive study, stakeholders will gain a brief idea regarding the growth of the apheresis market, and will be able to make informed business decisions. This detailed market study provides qualitative as well as quantitative data about the drivers, threats, restraints, and opportunities present in the apheresis market. The report also measures the impact of each of these dynamics to estimate the size of the apheresis market for the given period.
Authors of the report have taken ample care to measure and include the relevance and impact of microeconomic as well as macroeconomic factors that holds potential to influence growth of the apheresis market during the forecast period. The global study on the apheresis market includes Porter’s Five Forces analysis, in order to present the buyer’s and supplier’s power in the landscape. In addition, the analysis also discusses the threat of substitutes and new entrants, which provides a brief idea regarding the future growth course of the apheresis market.
The global study offers crucial information about global, regional, and local players operating in the apheresis market, along with their estimated market share. Market share has been estimated in terms of value (US$ Mn). Besides providing key information regarding the concentration of leading, prominent, and local players in the apheresis market, the study also aims at equipping stakeholders with the best of information regarding their winning strategies, recent developments, and financials.
Apheresis Market - Assessment of Key Segments
With an aim to offer granular level insights into the apheresis market, authors of the report have segmented the landscape on the basis of end user, technology, procedure, application, product, and region. This global research report also analyses the incremental opportunity available in the apheresis market during the forecast period. Key segments of the apheresis market include:
|
End User |
Technology |
Procedure |
Application |
Product |
Region |
|
Hospitals |
Centrifugation |
Plasmapheresis |
Renal Diseases |
Devices |
North America |
|
Blood Collection Centres
|
Membrane Filtration |
Photopheresis |
Neurology |
Disposables |
Europe |
|
|
|
LDL Apheresis |
Haematology |
|
Asia Pacific |
|
|
|
Plateletpheresis |
Cancer |
|
Latin America |
|
|
|
Leukapheresis |
Autoimmune Diseases |
|
Middle East &Africa |
|
|
|
Erythrocytapheresis |
Cardiovascular Diseases |
|
|
|
|
|
Others (Lymphapheresis and extracorporeal immunoadsorption) |
Others (Fibrosis and Diabetes) |
|
|
This detailed guide, based on the latest market movement, ensures that only precise information reaches stakeholders, so as to help them gain an upper hand over their competitors in the apheresis market. This exclusive guide offers crucial information about the current trends, pipeline drugs, unmet drugs, future scope, and government regulations for the apheresis market.
Key players profiled in this exclusive study on the apheresis market include Hemacare Corporation, Asahi Kasei Medical Co., Ltd, Therakos, Inc., B. Braun Melsungen AG, Terumo Corporation, Fresenius Medical Care, NIKKISO CO., LTD., Haemonetics Corp., Medica S.p.A., and Kawasumi Laboratories Inc.
Apheresis Market – Research Methodology
Research undertaken by seasoned analysts at Fact.MR consists of a systematic approach, including both, primary and secondary research methodologies. For conducting primary research, interviews and discussions were carried out with industry experts, key opinion leaders, vendors, and distributors. Besides these, respondents also include CEOs, presidents, directors, chairmen, vice presidents, marketing managers, suppliers, distributors, and chief medical officers, among others.
This helps in assessing the demand-supply gap prevailing in the apheresis market. In order to conduct secondary research, marketing collaterals, company websites, industry associations, and government statistics were studied. In addition to this, reports as well as content pieces published by credible sources, such as World Health Organization (WHO), PubMed (NCBI) articles, global and regional apheresis associations such as American Society for Apheresis (ASFA), American Association of Blood Banks (AABB), World Apheresis Association (WAA), U.S. Food and Drug Administration (FDA), Medical Dealer, Investing Daily, blogs, and others, were studied. Insights obtained through primary and secondary research are then authenticated with the data triangulation method.
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary
4. Market Definition
4.1. Introduction
4.1.1. Product/Service Definition
4.1.2. Industry Evolution / Developments
4.2. Market Overview
4.3. Key Market Indicators
4.3.1. Global Health Care Expenditure Scenario
4.4. Market Dynamics
4.4.1. Drivers
4.4.2. Restraints
4.4.3. Opportunities
4.5. Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast, 2016 – 2024
4.5.1. Market Revenue Projections (US$ Mn)
4.6. Apheresis Market (Therapeutic Apheresis & Donor Apheresis) - Global Supply Demand Scenario
4.7. Porter’s Five Force Analysis
4.8. Event Impact Analysis
4.9. Market Outlook
5. Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Product
5.1. Introduction & Definition
5.2. Key Findings / Developments
5.3. Key Trends
5.4. Market Size (US$ Mn) Forecast By Product
5.4.1. Devices
5.4.2. Disposables
5.5. Market Attractiveness By Product
6. Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast, By Application
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Key Trends
6.4. Market Size (US$ Mn) Forecast, By Application
6.4.1. Renal diseases
6.4.2. Neurology
6.4.3. Hematology
6.4.4. Cancer
6.4.5. Autoimmune disease
6.4.6. Cardiovascular diseases
6.4.7. Others (e.g. Fibrosis, Diabetes, Dermatology etc.)
6.5. Comparison Matrix
6.6. Market Attractiveness By Application
7. Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Procedure
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Key Trends
7.4. Market Size (US$ Mn) Forecast By Procedure
7.4.1. Plasmapheresis
7.4.2. Photopheresis
7.4.3. LDL-apheresis
7.4.4. Plateletpheresis
7.4.5. Leukapheresis
7.4.6. Erythrocytapheresis
7.4.7. Others (e.g. lymphapheresis, extracorporeal immunoadsorption, etc.)
7.5. Comparison Matrix
7.6. Market Attractiveness By Procedure
8. Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Technology
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Key Trends
8.4. Market Size (US$ Mn) Forecast By Technology
8.4.1. Centrifugation
8.4.2. Membrane filtration
8.5. Comparison Matrix
8.6. Market Attractiveness By Technology
9. Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By End User
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Key Trends
9.4. Market Size (US$ Mn) Forecast By End User
9.4.1. Hospitals
9.4.2. Blood Collection Centers
9.4.2.1. Public
9.4.2.2. private
9.5. Comparison Matrix
9.6. Market Attractiveness By End User
10. Global Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecasts, By Region
10.1. Key Findings
10.2. Policies and Regulations
10.3. Market Size (US$ Mn) Forecast By Region
10.3.1. North America
10.3.2. Europe
10.3.3. Asia Pacific
10.3.4. Latin America
10.3.5. Middle East & Africa
10.4. Market Attractiveness By Country/Region
11. North America Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
11.1. Introduction & Definition
11.2. Key Findings / Developments
11.3. Key Trends
11.4. Market Size (US$ Mn) Forecast, By Country
11.4.1. U.S.
11.4.2. Canada
11.5. Market Size (US$ Mn) Forecast By Product
11.5.1. Devices
11.5.2. Disposables
11.6. Market Size (US$ Mn) Forecast, By Application
11.6.1. Renal diseases
11.6.2. Neurology
11.6.3. Hematology
11.6.4. Cancer
11.6.5. Autoimmune disease
11.6.6. Cardiovascular diseases
11.6.7. Others
11.7. Market Size (US$ Mn) Forecast By Procedure
11.7.1. Plasmapheresis
11.7.2. Photopheresis
11.7.3. LDL-apheresis
11.7.4. Plateletpheresis
11.7.5. Leukapheresis
11.7.6. Erythrocytapheresis
11.7.7. Others
11.8. Market Size (US$ Mn) Forecast, By Technology
11.8.1. Centrifugation
11.8.2. Membrane filtration
11.9. Market Size (US$ Mn) Forecast, By End User
11.9.1. Hospitals
11.9.2. Blood Collection Centers
11.9.2.1. Public
11.9.2.2. private
11.10. Market Attractiveness Analysis
11.10.1. By Country
11.10.2. By Product
11.10.3. By Application
11.10.4. By Procedure
11.10.5. By Technology
11.10.6. By End User
12. Europe Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
12.1. Introduction & Definition
12.2. Key Findings / Developments
12.3. Key Trends
12.4. Market Size (US$ Mn) Forecast, By Country
12.4.1. Germany
12.4.2. France
12.4.3. U.K.
12.4.4. Italy
12.4.5. Spain
12.4.6. Rest of Europe
12.5. Market Size (US$ Mn) Forecast By Product
12.5.1. Devices
12.5.2. Disposables
12.6. Market Size (US$ Mn) Forecast, By Application
12.6.1. Renal diseases
12.6.2. Neurology
12.6.3. Hematology
12.6.4. Cancer
12.6.5. Autoimmune disease
12.6.6. Cardiovascular diseases
12.6.7. Others
12.7. Market Size (US$ Mn) Forecast By Procedure
12.7.1. Plasmapheresis
12.7.2. Photopheresis
12.7.3. LDL apheresis
12.7.4. Plateletpheresis
12.7.5. Leukapheresis
12.7.6. Erythrocytapheresis
12.7.7. Others
12.8. Market Size (US$ Mn) Forecast, By Technology
12.8.1. Centrifugation
12.8.2. Membrane filtration
12.9. Market Size (US$ Mn) Forecast, By End User
12.9.1. Hospitals
12.9.2. Blood Collection Centers
12.9.2.1. Public
12.9.2.2. private
12.10. Market Attractiveness Analysis
12.10.1. By Country
12.10.2. By Product
12.10.3. By Application
12.10.4. By Procedure
12.10.5. By Technology
12.10.6. By End User
13. Asia Pacific Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
13.1. Introduction & Definition
13.2. Key Findings / Developments
13.3. Key Trends
13.4. Market Size (US$ Mn) Forecast, By Country
13.4.1. Japan
13.4.2. China
13.4.3. India
13.4.4. Australia
13.4.5. Rest of Asia Pacific
13.5. Market Size (US$ Mn) Forecast By Product
13.5.1. Devices
13.5.2. Disposables
13.6. Market Size (US$ Mn) Forecast, By Application
13.6.1. Renal diseases
13.6.2. Neurology
13.6.3. Hematology
13.6.4. Cancer
13.6.5. Autoimmune disease
13.6.6. Cardiovascular diseases
13.6.7. Others
13.7. Market Size (US$ Mn) Forecast By Procedure
13.7.1. Plasmapheresis
13.7.2. Photopheresis
13.7.3. LDL-apheresis
13.7.4. Plateletpheresis
13.7.5. Leukapheresis
13.7.6. Erythrocytapheresis
13.7.7. Others
13.8. Market Size (US$ Mn) Forecast, By Technology
13.8.1. Centrifugation
13.8.2. Membrane filtration
13.9. Market Size (US$ Mn) Forecast, By End User
13.9.1. Hospitals
13.9.2. Blood Collection Centers
13.9.2.1. Public
13.9.2.2. private
13.10. Market Attractiveness Analysis
13.10.1. By Country
13.10.2. By Product
13.10.3. By Application
13.10.4. By Procedure
13.10.5. By Technology
13.10.6. By End User
14. Latin America Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
14.1. Introduction & Definition
14.2. Key Findings / Developments
14.3. Key Trends
14.4. Market Size (US$ Mn) Forecast, By Country
14.4.1. Brazil
14.4.2. Mexico
14.4.3. Rest of Latin America
14.5. Market Size (US$ Mn) Forecast By Product
14.5.1. Devices
14.5.2. Disposables
14.6. Market Size (US$ Mn) Forecast, By Application
14.6.1. Renal diseases
14.6.2. Neurology
14.6.3. Hematology
14.6.4. Cancer
14.6.5. Autoimmune disease
14.6.6. Cardiovascular diseases
14.6.7. Others
14.7. Market Size (US$ Mn) Forecast By Procedure
14.7.1. Plasmapheresis
14.7.2. Photopheresis
14.7.3. LDL-apheresis
14.7.4. Plateletpheresis
14.7.5. Leukapheresis
14.7.6. Erythrocytapheresis
14.7.7. Others
14.8. Market Size (US$ Mn) Forecast, By Technology
14.8.1. Centrifugation
14.8.2. Membrane filtration
14.9. Market Size (US$ Mn) Forecast, By End User
14.9.1. Hospitals
14.9.2. Blood Collection Centers
14.9.2.1. Public
14.9.2.2. private
14.10. Market Attractiveness Analysis
14.10.1. By Country
14.10.2. By Product
14.10.3. By Application
14.10.4. By Procedure
14.10.5. By Technology
14.10.6. By End User
15. Middle East & Africa Apheresis Market (Therapeutic Apheresis & Donor Apheresis) Analysis and Forecast
15.1. Introduction & Definition
15.2. Key Findings / Developments
15.3. Key Trends
15.4. Market Size (US$ Mn) Forecast, By Country
15.4.1. Saudi Arabia
15.4.2. South Africa
15.4.3. Rest of MEA
15.5. Market Size (US$ Mn) Forecast By Product
15.5.1. Devices
15.5.2. Disposables
15.6. Market Size (US$ Mn) Forecast, By Application
15.6.1. Renal diseases
15.6.2. Neurology
15.6.3. Hematology
15.6.4. Cancer
15.6.5. Autoimmune disease
15.6.6. Cardiovascular diseases
15.6.7. Others
15.7. Market Size (US$ Mn) Forecast By Procedure
15.7.1. Plasmapheresis
15.7.2. Photopheresis
15.7.3. LDL-apheresis
15.7.4. Plateletpheresis
15.7.5. Leukapheresis
15.7.6. Erythrocytapheresis
15.7.7. Others
15.8. Market Size (US$ Mn) Forecast, By Technology
15.8.1. Centrifugation
15.8.2. Membrane filtration
15.9. Market Size (US$ Mn) Forecast, By End User
15.9.1. Hospitals
15.9.2. Blood Collection Centers
15.9.2.1. Public
15.9.2.2. private
15.10. Market Attractiveness Analysis
15.10.1. By Country
15.10.2. By Product
15.10.3. By Application
15.10.4. By Procedure
15.10.5. By Technology
15.10.6. By End User
16. Competition Landscape
16.1. Market Player – Competition Matrix (By Tier and Size of companies)
16.2. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
16.2.1. Asahi Kasei Medical Co., Ltd.
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Product Portfolio
16.2.1.3. SWOT Analysis
16.2.1.4. Financial Overview
16.2.1.5. Strategic Overview
16.2.2. B. Braun Melsungen AG
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Product Portfolio
16.2.2.3. SWOT Analysis
16.2.2.4. Financial Overview
16.2.2.5. Strategic Overview
16.2.3. Cerus Corporation
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Product Portfolio
16.2.3.3. SWOT Analysis
16.2.3.4. Financial Overview
16.2.3.5. Strategic Overview
16.2.4. Fresenius Medical Care
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Product Portfolio
16.2.4.3. SWOT Analysis
16.2.4.4. Financial Overview
16.2.4.5. Strategic Overview
16.2.5. Haemonetics Corp.
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Product Portfolio
16.2.5.3. SWOT Analysis
16.2.5.4. Financial Overview
16.2.5.5. Strategic Overview
16.2.6. Hemacare Corporation
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Product Portfolio
16.2.6.3. SWOT Analysis
16.2.6.4. Financial Overview
16.2.6.5. Strategic Overview
16.2.7. Kawasumi Laboratories Inc.
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Product Portfolio
16.2.7.3. SWOT Analysis
16.2.7.4. Financial Overview
16.2.7.5. Strategic Overview
16.2.8. Medica S.p.A.
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Product Portfolio
16.2.8.3. SWOT Analysis
16.2.8.4. Financial Overview
16.2.8.5. Strategic Overview
16.2.9. NIKKISO CO., LTD.
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Product Portfolio
16.2.9.3. SWOT Analysis
16.2.9.4. Financial Overview
16.2.9.5. Strategic Overview
16.2.10. Terumo Corporation
16.2.10.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.10.2. Product Portfolio
16.2.10.3. SWOT Analysis
16.2.10.4. Financial Overview
16.2.10.5. Strategic Overview
16.2.11. Therakos, Inc.
16.2.11.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.11.2. Product Portfolio
16.2.11.3. SWOT Analysis
16.2.11.4. Financial Overview
16.2.11.5. Strategic Overview
Fact.MR offers custom research services that help clients to get specific research solutions
We are committed towards customer satisfaction and quality service.
Apheresis Market Forecast, Trend Analysis & Competition Tracking - Global Market Insights 2020 to 2025